Aclaris Therapeutics Inc (ACRS)

Cost of Revenue

$361.00K

TTM · Period ending: · USD

ACRS logo

ACRS Cost of Revenue

Latest reported$361.00K
ACRS TTM Cost of Revenue ($0.00 → $361.00K)
High-resolution chart · PNG

ACRS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aclaris Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
361,000
1,980,000
2,091,000
12,195,000
14,065,000
14,124,000
15,458,000
12,585,000
18,369,000
18,052,000
18,081,000
13,167,000
13,198,000
12,674,000
11,960,000
11,595,000
4,471,000
4,666,000
4,713,000
4,850,000
4,940,000
5,066,000
5,133,000
4,874,000
4,511,000
5,825,000
7,333,000
9,815,000
10,182,000
8,660,000
6,850,000
4,095,000
3,355,000
2,174,000
1,207,000
453,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.